we calculated risk-standardized mortality rates and risk-standardized readmission rates for ranked and nonranked hospitals in the treatment of heart failure. The mortality analysis examined 14 813 patients in 50 ranked hospitals and 409 806 patients in 4761 nonranked hospitals. The readmission analysis included 16 641 patients in 50 ranked hospitals and 458 473 patients in 4627 nonranked hospitals. Mean 30-day risk-standardized mortality rates were lower in ranked versus nonranked hospitals (10.1% versus 11.2%, PϽ0.01), whereas mean 30-day riskstandardized readmission rates were no different between ranked and nonranked hospitals (23.6% versus 23.8%, Pϭ0.40). The 30-day risk-standardized mortality rates varied widely for both ranked and nonranked hospitals, ranging from 7.9% to 12.4% for ranked hospitals and from 7.1% to 17.5% for nonranked hospitals. The 30-day risk-standardized readmission rates also spanned a large range, from 18.7% to 29.3% for ranked hospitals and from 19.2% to 29.8% for nonranked hospitals. Surgery" are more likely than nonranked hospitals to have a significantly lower than expected 30-day mortality rate, but there was much overlap in performance. For readmission, the rates were similar in ranked and nonranked hospitals. (Circ Cardiovasc Qual Outcomes. 2009;2:558-565.)
U .S. News & World Report's annual issue featuring "America's Best Hospitals" is one of the most prominent evaluations of hospital quality in the United States. With more than 2 million copies in circulation, 1 the rankings are well known to the general public. However, the extent to which ranked hospitals provide superior routine care is not clear. Even for a common condition like heart failure (HF), the most frequent cause of admission for Medicare beneficiaries, it is not known whether outcomes are better at America's Best Heart Hospitals. 2 The recent development of the Centers for Medicare & Medicaid Services' mortality and readmission models for profiling hospital performance in the care of patients with HF provides an opportunity to assess the validity of the U.S. News & World Report rankings.
The assessment of mortality and readmission also allows an investigation into whether these outcomes are correlated in this group of prominent hospitals compared with nonranked hospitals. The Medicare Payment Advisory Commission (MedPAC), an independent federal body that advises the US Congress, estimates that 13.3% of hospital readmissions at 30 days are preventable, and has identified readmissions after a hospitalization for HF as a priority problem for the healthcare system. 3 The hospital policies and procedures that affect readmissions, however, may be different from those that are important for mortality. Readmission after discharge may be more dependent than mortality on preparation for discharge, the coordination with outpatient services, and the instructions about outpatient regimens.
We compared mortality and readmission in hospitals identified by U.S. News & World Report 4 ("ranked hospitals") for patients admitted with HF to that in hospitals not included on the U.S. News & World Report list ("nonranked hospitals") using 30-day mortality 5 /readmission-risk 6 models endorsed by the National Quality Forum. This study extends a recent study of acute myocardial infarction, 7 which found that U.S. News & World Report's ranked hospitals had lower 30-day mortality rates compared with nonranked hospitals, but many more nonranked hospitals than ranked hospitals had significantly lower than expected mortality rates.
WHAT IS KNOWN
• The rankings of "America's Best Hospitals" by U.S.
News & World Report are influential, but the performance of ranked hospitals in caring for patients with routine cardiac conditions such as heart failure is not well understood.
WHAT THE STUDY ADDS
• The 50 hospitals ranked by U.S. News & World Report as "America's Best Hospitals" in "Heart & Heart Surgery" are more likely than nonranked hospitals to have a significantly lower than expected 30-day mortality rate for the treatment of heart failure, but there was much overlap in performance. • The readmission rates for patients with heart failure were similar in ranked and nonranked hospitals, which suggests that the hospital factors that produce better mortality rates may not be the ones that are important for readmission.
Methods

Hospital Sample and Characteristics
In the 2006 U.S. News & World Report published list of "America's Best Hospitals," 50 hospitals were designated as the best hospitals in "Heart and Heart Surgery." 4 To be considered as a ranked hospital, the U.S. News & World Report methodology 8 required that a hospital have at least 1 of the following characteristics: (1) member of the Council of Teaching Hospitals, (2) affiliation with a medical school, or (3) having at least 8 of 19 possible hospital-wide technologies or services available. Additionally, hospitals were required to have at least 500 surgical and 1005 medical cardiovascular discharges during the time period of the study. A total of 596 hospitals that satisfied these criteria were assigned a composite score based on 3 separate equally weighted measures: process, outcome, and structure. The process measure consisted of a reputation survey (a proxy for an evaluation of hospital process scores) compiled from a nationwide sample of Ϸ200 cardiologists and cardiac surgeons identifying the top 5 institutions for care. The outcome measures consisted of inpatient mortality data derived from Medicare Provider Analysis and Review files for cardiovascular diagnoses and readmission data from the Standard Analytic Files for patients enrolled in Medicare fee-for-service. 9 The structure measure incorporated technology (eg, positron emission tomography scanner capability), patient volume, hospital status as a trauma center, presence of a cardiac intensive care unit, patient services (such as availability of hospice, palliative care, and pain management programs), and recognition by external organizations (eg, American Nurse Credentialing Center). From this method, 50 hospitals were identified, and they represented the ranked hospitals that we compare in this study. We used the hospital rankings published in 2006 because they corresponded to the most recent period for which Medicare data are available. A single Medicare Provider Identification Number was used to identify each ranked institution. In cases where more than 1 Medicare Provider Identification Number was associated with a ranked institution, the Identification Number associated with the majority of the institution's total patient beds and annual revenue was chosen. We compared ranked hospitals from the U.S. News & World Report list with all nonranked hospitals for which Medicare data from 2006 were available. Hospital characteristics collected included status as a Council of Teaching Hospitals member or affiliation with a medical school as reported by the American Hospital Association. 10
Patient Sample and Characteristics
The sample included Medicare patients 65 years and older with a principal discharge diagnosis of HF from July 1, 2005 11 We obtained data from the 2005 to 2006 Standard Analytic Files that included principal discharge and secondary diagnosis codes, and procedure codes for each hospitalization for Medicare patients enrolled in the fee-for-service plan.
Information for baseline patient characteristics was obtained from additional data from diagnosis codes recorded 12 months before the index admission from Medicare Part A and B data; thus, we included inpatient and outpatient codes. For the mortality analysis, patients who were transferred between acute care facilities were included if their principal discharge diagnosis was HF at both hospitals; for included transferred patients, both episodes of care were linked into a single episode with outcomes attributed to the first hospital. For the readmission analysis, only patients who were discharged to a nonacute setting were included, and the outcomes were attributed to the hospital from which they were discharged. We selected comorbid conditions only from the first hospitalization to avoid misclassifying complications as comorbid conditions during the linked episode of care. Because both models incorporate diagnosis codes up to 12 months before the index hospitalization, we included only patients enrolled in the Medicare fee-for-service plan for at least 1 year.
In addition to these criteria, there were separate inclusion and exclusion criteria for the mortality and readmission models, resulting in different total numbers of admissions and of hospitals included in each analysis. The mortality model, for example, randomly selected 1 admission per patient, whereas the readmission model accommodated potential multiple admissions for a single patient. 12, 13 Furthermore, admissions were only counted for the purposes of the readmission analysis if the patient was discharged to a nonacute care setting, but there was no such discharge requirement for inclusion in the mortality analysis. Because of the difference in the inclusion/ exclusion criteria of the mortality and readmission models, each analysis included a different subset of the Medicare admissions pool. The admission samples overlap partially, but the hospitalizations in one analysis are not a subset of the admissions in the other.
Outcomes and Risk-Adjustment Variables
The mortality outcome was defined as death from any cause within 30 days from the date of admission. The readmission outcome was defined as hospitalization in any U.S. acute care hospital for any cause within 30 days of discharge from an index hospitalization for HF. To account for the possibility of multiple hospital admissions for individual patients during the study period, a distinction was made between index hospitalizations and readmissions. Each individual HF hospital admission was considered either an index hospitalization or a readmission. For each index hospitalization, 1 or more rehospitalizations within 30 days resulted in that index admission being designated as one that resulted in readmission. In each case of readmission, the hospital that discharged the patient to a nonacute setting was charged with the readmission. If a patient died in the hospital or was transferred to another acute care facility, the admission was excluded. Deaths were ascertained from the Medicare enrollment files by linking unique patient identifiers.
Statistical Analysis
Our analytic approach at a patient and hospital level involved 5 steps. First, we computed bivariate summaries at the patient level. Second, we estimated hierarchical logistic regression models to characterize the association between patient outcome and risk factors. Third, we calculated hospital-specific summaries for mortality and readmission to: (1) account for the variance in patient outcomes within and between hospitals (risk-standardized mortality rate [RSMR] and risk-standardized readmission rate [RSRR]) 14 and (2) determine which hospitals had outcomes that were better (ie, lower) than expected (standardized mortality ratios [SMRs] and standardized readmission ratios [SRRs]). Fourth, we used a bootstrapping procedure to generate a 95% interval estimate (IE) for each SMR or SRR. Lastly, to incorporate all the sources of uncertainty into a single summary, we estimated the likelihood that a hospital was a "good" performer. This was operationalized using a bootstrapping algorithm to estimate the probability that the SMR (and again that the SRR) for each hospital was 10% smaller than expected.
Patient-Level Analyses
We compared baseline characteristics of patients by hospital type (ranked and nonranked) using a 2 test for categorical variables and t test for continuous variables. We also calculated observed inhospital, 30-day mortality rates, and 30-day readmission rates and compared the 2 hospital groups.
Risk Adjustment
We estimated separate hierarchical logistic regression models to characterize the association between patient outcome and risk factors. For mortality, 24 patient variables used in risk adjustment were based on a previously developed administrative claims model and included demographic, cardiovascular and comorbidity variables. 5 For readmission, 37 patient characteristics used in riskadjustment included demographic, cardiovascular, and comorbidity variables identified as impacting 30-day readmission in the previously discussed administrative claims model. 6
Hospital-Specific Estimates
Based on the estimates obtained from the logistic regression models, we calculated 2 types of hospital-specific summaries for each outcome: rates and ratios. Hospital-specific RSMRs and RSRRs accounted for the variance in patient outcomes within and between hospitals 14 and represent the mortality (or readmission) rate for a particular hospital using the observed case-mix of its HF patients and applying the risks associated with these characteristics based on the overall sample. SMRs and SRRs were calculated for each hospital to determine which hospitals had outcomes that were better (ie, lower) than expected. These standardized ratios are the ratio of a hospital's predicted-to-expected mortality/readmission rates (the "expected" number in each hospital is estimated using its patient mix and the average hospital-specific intercept, whereas the "predicted" number is estimated given the same patient mix but uses the hospital-specific intercept).
Classifying Hospitals
A hospital with lower than expected mortality (or readmission) would have an SMR (or SRR) less than 1.0. A hospital with higher than expected mortality would have an SMR/SRR greater than 1.0. For each hospital, we used a bootstrapping procedure based on 1000 samples to generate a 95% IE for each hospital SMR and SRR. We designated hospitals with either an SMR or SRR significantly less than 1.0 (defined by a 95% IE with an upper limit less than 1.0) and then cross-classified hospitals by this new designation and by the U.S. News & World Report rank status.
Comparing Ranked With Nonranked Hospital Performance
We calculated the relative risk ratio for a ranked hospital to have an SMR (or SRR) significantly less than 1.0 compared with nonranked teaching hospitals using a bivariate analysis at the hospital level. We calculated the probability that the SMR and SRR of each ranked and nonranked hospital was less than 0.9. This provided a quantitative measure of how sure we were that the hospital's mortality (or readmission) was at least 10% smaller than expected. Bootstrapping procedures were used to determine this probability. We created box plots illustrating the interval and point estimates of RSMRs and RSRRs for the ranked and nonranked hospitals. The analyses were conducted using SAS statistical software (version 9.1.3; SAS Institute Inc). The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
A total of 424 619 patients were treated in the 4811 hospitals where mortality rates were examined. Compared with patients (nϭ409 806) admitted to nonranked hospitals (nϭ4761), patients (nϭ14 813) admitted to ranked hospitals (nϭ50) were similar in age and prevalence of many comorbidities (Table  1) . Patients admitted to ranked hospitals were more likely to have valvular heart disease (32.5% versus 28.5%, PϽ0.001) or a history of HF (72.8% versus 68.3%, PϽ0.001). Patients admitted to nonranked hospitals were more likely to be female (58.1% versus 53.3%, PϽ0.001).
The readmission analysis incorporated a total of 475 114 patients treated in 4677 hospitals. Compared with patients (nϭ458 473) admitted to nonranked hospitals (nϭ4627), patients (nϭ16 641) admitted to ranked hospitals (nϭ50) were similar in age and prevalence of many comorbidities (Table 1) , but were significantly more likely to have a host of cardiovascular problems, including a history of coronary artery bypass graft surgery (13.9% versus 12.8%, PϽ0.001), arrhythmias (69.6% versus 61.5%, PϽ0.001), valvular or rheumatic heart disease (57.2% versus 48.4%, PϽ0.001), and angina (77.4% versus 73.6%, PϽ0.001). Patients admitted to nonranked hospitals were more likely to be female (56.8% versus 50.7%, PϽ0.001).
In accordance with U.S. News & World Report criteria, all ranked institutions were teaching-affiliated. Among the nonranked hospitals, 17.3% of those included in the mortality analysis and 15.2% of those in the readmission analysis were teaching-affiliated. The volume statistics in both analyses were similar, with the median [Q1 and Q3] volume of fee-for-service Medicare patients treated for HF at ranked hospitals being larger than that for nonranked hospitals ( 
Mortality
The mean observed in-hospital mortality rate was significantly lower in ranked versus nonranked hospitals (4.2% versus 4.8%, Pϭ0.002), as was 30-day mortality (9.3% versus 11.2%, PϽ0.001; Table 1 ). After adjustment for patient characteristics, mean 30-day RSMRs were lower in ranked versus nonranked hospitals (10.1% versus 11.2%, PϽ0.01; Table 2 ). However, the 30-day RSMR varied widely for both groups, ranging from 7.9% to 12.4% for ranked hospitals and from 7.1% to 17.5% for nonranked hospitals. Figure 1 displays the distributions represented in a side-byside comparison. Of the 4761 nonranked hospitals in our study, 1255 (26.4%) had on-site facilities for coronary artery bypass graft surgery or were designated as a teaching hospital. The mean (SD) RSMR for these nonranked teaching hospitals or hospitals with coronary artery bypass graft surgery was 11.0% (1.5%) versus 9.9% (1.1%) for ranked hospitals (PϽ0.001).
The SMRs for ranked hospitals revealed 7 institutions (14%) with SMRs significantly below the expected mortality for all nonranked and ranked hospitals. Of the remaining ranked hospitals, none were statistically significantly higher than expected given baseline patient characteristics. The mean (SE) SMR for ranked hospitals was 0.90 (0.10), with a range of 0.74 to 1.10 (Figure 1 ). In comparison, 36 nonranked hospitals (0.79%) had an SMR significantly less than 1.0. The relative risk ratio for a ranked hospital to have an SMR significantly less than 1.0 compared with nonranked hospitals was 18.5 (95% confidence interval, 8.7 to 39.6). The probability that a given (ranked or nonranked) hospital had an RSMR less than 0.9 times the risk-standardized mean is shown in Figure 2 . The average difference between the ranked and nonranked groups in this area favors the performance of the ranked hospitals, but some individual nonranked hospitals have a high probability of being a high-performing (RSMR Ͻ90% of the mean) hospital and some ranked hospitals have a low probability of achieving that distinction.
Readmission
The mean observed readmission rate was not significantly different in ranked versus nonranked hospitals (23.9% versus 23.8%, Pϭ0.63; Table 1 ). After adjustment for patient characteristics, mean 30-day RSRRs ( Table 2) were substantially similar in ranked versus nonranked hospitals (23.6% versus 23.8%, Pϭ0.40). As in the mortality analysis, the 30-day RSRR ranged widely and similarly in both groups, from 18.7% to 29.3% for ranked hospitals and from 19.2% to 29.8% for nonranked hospitals.
The SRRs for ranked hospitals revealed 4 institutions (8%) with SRRs significantly below the average expected readmission rate for all ranked and nonranked hospitals. Neither of these hospitals had an SMR significantly better than expected, meaning there was no crossover between the group of ranked hospitals that excelled in preventing mortality and the group that excelled in preventing readmission. Of the remaining ranked hospitals, 2 were statistically significantly higher than what was expected given baseline patient characteristics. The mean (SE) SRR for ranked hospitals was 1.00 (0.01), with a range of 0.79 to 1.23 (Figure 1 ). Among nonranked hospitals, 19 (0.41%) had an SRR significantly less than 1.0. The relative risk ratio for a ranked hospital to have an SRR significantly less than 1.0 compared with nonranked hospitals was 19.5 (6.9 to 55.2). The probability that a given (ranked or nonranked) hospital had an RSRR less than 90% of the risk-standardized mean is shown in Figure 2 . The average difference between the 2 groups in these probabilities slightly favors the nonranked institutions, but the probabilities that hospitals in either group will outperform the mean fall in a much narrower range for readmission than they do for mortality.
Discussion
Our study demonstrates that the hospitals ranked by the U.S. News & World Report for heart disease care, some of the nation's best known institutions, have mixed outcomes for the care of patients with HF, the most common heart diseaserelated reason for admission to the hospital. For 30-day mortality, these hospitals tended to do better than nonranked hospitals, with ranked hospitals being much more likely to do significantly better than expected based on their case mix. The absolute differences, however, were modest, and there was much overlap between the ranked and nonranked hospitals. For 30-day readmission, however, the advantage of ranked hospitals over nonranked hospitals was even less clear. Despite the fact that a ranked institution is more likely than a nonranked institution to have an SRR less than 1.0, this is based on only 4 hospitals with that distinction, and the RSMRs in the ranked and nonranked groups were almost identical (23.6% and 23.8%, respectively).
The findings for mortality rates are consistent with the results that were recently reported for the care of patients with an acute myocardial infarction 7 ; for HF and acute myocardial infarction, ranked hospitals had, on average, better mortality rates. However, in both cases there was marked heterogeneity of performance within the group, with substantial overlap with nonranked hospitals. Although the likelihood of ranked hospitals being better than expected was almost 20-fold that of nonranked hospitals, there were many more nonranked hospitals with RSMRs that were significantly better than expected. The 50 hospitals ranked by U.S. News & World Report in 2006 represent slightly more than 1% of our nationwide cohort and are distributed in 22 states and the District of Columbia, with 38% of these institutions located in Illinois, Ohio, Pennsylvania, and California. Distribution of hospitals with low RSMRs, however, was much more widespread, with 392 hospitals in the top decile of performance spread across 38 states and the District of Columbia.
For readmission, the ranked hospitals had no substantial evidence of superiority. This signals the possibility that the rankings place strong emphasis on inpatient care but not on the transition from inpatient to outpatient status. There are many interventions that have been shown to reduce readmission rates, but they have tended to be reimbursed poorly, if at all, and not to involve extensive testing or procedures. 15 These interventions have generally involved teaching and monitoring.
The difference in the mortality and readmission outcomes is an especially salient finding of this study. There is a sharp contrast between the likelihood that a ranked hospital will outperform the risk standardized mean (Ͻ0.9 of the mean) in mortality and the probability that it will do so for readmission, the former being much more likely than the latter. That is, ranked hospitals are much more likely to excel in preventing mortality than readmission in cases of HF ( Figure 2 ). It is also noteworthy that among ranked hospitals, there was no overlap between the 7 that performed better than expected on mortality and the 2 that performed better than expected on readmission. This result suggests that mortality and readmission outcomes are measuring distinct domains of quality. The factors that may be promoting better survival in these patients may not be working to reduce the possibility of readmission.
The validity of the findings in this study depends on the strength of the risk-adjustment model. The model makes use of administrative claims data, as there is no national clinical dataset that is available for assessing the outcomes of patients with HF. This model has been shown to produce results that are similar to the output of an excellent model based on medical record data. 6 Moreover, the mortality and readmission models have been approved by the National Quality Forum, and the mortality model is the basis for the current public reporting of HF outcomes by the Centers for Medicare & Medicaid Services. Nevertheless, it is possible that there are unmeasured factors, not related to the quality of care, that are associated with outcomes. Such factors might include the elective admission of HF patients to ranked hospitals for procedures. The existence of such factors, however, would be unlikely to change our findings that the ranking system does not discriminate well based on RSMR and RSRR. In addition, the models do not contain sociodemographic variables, as the interest is in comparing hospital performance independent of social factors. If, for example, race is associated with lower quality care and worse outcomes, then adjusting for race would obscure the fact that hospitals with a disproportionately high population of black patients perform worse. Con-sequently, the National Quality Forum-approved risk models do not contain these variables.
There are several issues to consider in the interpretation of this study. The observation that ranking does not directly translate into uniformly better outcomes for patients with HF is not a criticism of the ranking, which is not designed to assess the quality of care for routine conditions. The purpose of these rankings is to identify hospitals that provide the best care for complex conditions. 8 Nevertheless, the ranking system does identify a list of many of the nation's well known teaching hospitals. It is reasonable to expect that institutions identified as the top heart hospitals in the United States would achieve outstanding performance in the care of the most common cause of acute care hospital admissions of Medicare beneficiaries. 16, 17 
Conclusion
Hospitals ranked by U.S. News & World Report for heart disease are much more likely than nonranked hospitals to have a significantly lower than expected 30-day mortality rate, but the differences are modest. However, across the nation there are many more nonranked hospitals with significantly lower than expected rates. For readmission, there is little evidence of better performance by the ranked hospitals, indicating that outstanding performance in this area is not the sole province of the country's best known teaching institutions. These findings also suggest that the hospital factors that may produce better mortality rates may not be the ones that are important for readmission.
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